BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

323 related articles for article (PubMed ID: 34416159)

  • 1. The impact of scaling up access to treatment and imaging modalities on global disparities in breast cancer survival: a simulation-based analysis.
    Ward ZJ; Atun R; Hricak H; Asante K; McGinty G; Sutton EJ; Norton L; Scott AM; Shulman LN
    Lancet Oncol; 2021 Sep; 22(9):1301-1311. PubMed ID: 34416159
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role and contribution of treatment and imaging modalities in global cervical cancer management: survival estimates from a simulation-based analysis.
    Ward ZJ; Grover S; Scott AM; Woo S; Salama DH; Jones EC; El-Diasty T; Pieters BR; Trimble EL; Vargas HA; Hricak H; Atun R
    Lancet Oncol; 2020 Aug; 21(8):1089-1098. PubMed ID: 32758463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimating the impact of treatment and imaging modalities on 5-year net survival of 11 cancers in 200 countries: a simulation-based analysis.
    Ward ZJ; Scott AM; Hricak H; Abdel-Wahab M; Paez D; Lette MM; Vargas HA; Kingham TP; Atun R
    Lancet Oncol; 2020 Aug; 21(8):1077-1088. PubMed ID: 32758462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Global costs, health benefits, and economic benefits of scaling up treatment and imaging modalities for survival of 11 cancers: a simulation-based analysis.
    Ward ZJ; Scott AM; Hricak H; Atun R
    Lancet Oncol; 2021 Mar; 22(3):341-350. PubMed ID: 33662286
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Global childhood cancer survival estimates and priority-setting: a simulation-based analysis.
    Ward ZJ; Yeh JM; Bhakta N; Frazier AL; Girardi F; Atun R
    Lancet Oncol; 2019 Jul; 20(7):972-983. PubMed ID: 31129029
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estimating the total incidence of global childhood cancer: a simulation-based analysis.
    Ward ZJ; Yeh JM; Bhakta N; Frazier AL; Atun R
    Lancet Oncol; 2019 Apr; 20(4):483-493. PubMed ID: 30824204
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expanding global access to radiotherapy.
    Atun R; Jaffray DA; Barton MB; Bray F; Baumann M; Vikram B; Hanna TP; Knaul FM; Lievens Y; Lui TY; Milosevic M; O'Sullivan B; Rodin DL; Rosenblatt E; Van Dyk J; Yap ML; Zubizarreta E; Gospodarowicz M
    Lancet Oncol; 2015 Sep; 16(10):1153-86. PubMed ID: 26419354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Early detection and treatment strategies for breast cancer in low-income and upper middle-income countries: a modelling study.
    Birnbaum JK; Duggan C; Anderson BO; Etzioni R
    Lancet Glob Health; 2018 Aug; 6(8):e885-e893. PubMed ID: 30012269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Forecasting life expectancy, years of life lost, and all-cause and cause-specific mortality for 250 causes of death: reference and alternative scenarios for 2016-40 for 195 countries and territories.
    Foreman KJ; Marquez N; Dolgert A; Fukutaki K; Fullman N; McGaughey M; Pletcher MA; Smith AE; Tang K; Yuan CW; Brown JC; Friedman J; He J; Heuton KR; Holmberg M; Patel DJ; Reidy P; Carter A; Cercy K; Chapin A; Douwes-Schultz D; Frank T; Goettsch F; Liu PY; Nandakumar V; Reitsma MB; Reuter V; Sadat N; Sorensen RJD; Srinivasan V; Updike RL; York H; Lopez AD; Lozano R; Lim SS; Mokdad AH; Vollset SE; Murray CJL
    Lancet; 2018 Nov; 392(10159):2052-2090. PubMed ID: 30340847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Scale-up of radiotherapy for cervical cancer in the era of human papillomavirus vaccination in low-income and middle-income countries: a model-based analysis of need and economic impact.
    Rodin D; Burger EA; Atun R; Barton M; Gospodarowicz M; Grover S; Hanna TP; Jaffray DA; Knaul FM; Lievens Y; Zubizarreta E; Milosevic M
    Lancet Oncol; 2019 Jul; 20(7):915-923. PubMed ID: 31151906
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improving outcomes in breast cancer for low and middle income countries.
    Yip CH; Buccimazza I; Hartman M; Deo SV; Cheung PS
    World J Surg; 2015 Mar; 39(3):686-92. PubMed ID: 25398564
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Global maternal mortality projections by urban/rural location and education level: a simulation-based analysis.
    Ward ZJ; Atun R; King G; Dmello BS; Goldie SJ
    EClinicalMedicine; 2024 Jun; 72():102653. PubMed ID: 38800798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries.
    Allemani C; Matsuda T; Di Carlo V; Harewood R; Matz M; Nikšić M; Bonaventure A; Valkov M; Johnson CJ; Estève J; Ogunbiyi OJ; Azevedo E Silva G; Chen WQ; Eser S; Engholm G; Stiller CA; Monnereau A; Woods RR; Visser O; Lim GH; Aitken J; Weir HK; Coleman MP;
    Lancet; 2018 Mar; 391(10125):1023-1075. PubMed ID: 29395269
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of scaling up prenatal nutrition interventions on human capital outcomes in low- and middle-income countries: a modeling analysis.
    Perumal N; Blakstad MM; Fink G; Lambiris M; Bliznashka L; Danaei G; Sudfeld CR
    Am J Clin Nutr; 2021 Nov; 114(5):1708-1718. PubMed ID: 34320177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The global need and availability of blood products: a modelling study.
    Roberts N; James S; Delaney M; Fitzmaurice C
    Lancet Haematol; 2019 Dec; 6(12):e606-e615. PubMed ID: 31631023
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Timing and cost of scaling up surgical services in low-income and middle-income countries from 2012 to 2030: a modelling study.
    Verguet S; Alkire BC; Bickler SW; Lauer JA; Uribe-Leitz T; Molina G; Weiser TG; Yamey G; Shrime MG
    Lancet Glob Health; 2015 Apr; 3 Suppl 2():S28-37. PubMed ID: 25926318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estimating the impact of the COVID-19 pandemic on diagnosis and survival of five cancers in Chile from 2020 to 2030: a simulation-based analysis.
    Ward ZJ; Walbaum M; Walbaum B; Guzman MJ; Jimenez de la Jara J; Nervi B; Atun R
    Lancet Oncol; 2021 Oct; 22(10):1427-1437. PubMed ID: 34487693
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 17.